Picture of MiCo BioMed Co logo

214610 MiCo BioMed Co Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for MiCo BioMed Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

R2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue3,5854,09845,67230,30216,111
Cost of Revenue
Gross Profit-698-50520,91914,787-403
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses12,10417,81342,24441,19743,090
Operating Profit-8,519-13,7153,428-10,895-26,978
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-8,757-14,655-5,789-10,598-38,932
Provision for Income Taxes
Net Income After Taxes-8,757-14,639-5,776-10,585-38,919
Minority Interest
Net Income Before Extraordinary Items
Net Income-8,749-14,632-5,776-10,575-38,893
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-8,749-14,632-5,776-10,575-38,893
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-536-511-253-372-1,335
Dividends per Share
0